Table 2 Outcome of the patients
From: Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients
All patients (n = 140) | No delirium and normal neurological examination (N = 22) | Delirium and/or abnormal neurological examination (N = 118) | p | |
|---|---|---|---|---|
Invasive mechanical ventilation | ||||
Duration (days)—median [IQR] | 13 [9; 23] | 9 [5; 17] | 14 [10; 25] | 0.011 |
Auto-extubation with immediate reintubation—n (%) | 11 (7.9) | 0 (0.0) | 11 (9.3) | 0.211 |
ICU stay | ||||
ICU mortality—n (%) | 21 (15.0) | 2 (9.1) | 19 (16.1) | 0.634 |
Length of stay (days)—median [IQR] | 15 [10; 25] | 10 [6; 21] | 15 [11; 25] | 0.017 |
Sedative treatments | ||||
Midazolam—n (%) | 121 (86.4) | 18 (81.8) | 103 (87.3) | 0.691 |
Midazolam (days)—median [IQR] | 6 [3; 12] | 4 [1; 9] | 7 [4; 12] | 0.095 |
Sufentanil—n (%) | 138 (98.6) | 20 (90.9) | 118 (100) | 0.047 |
Sufentanil—median [IQR] | 10 [5; 15] | 6 [1; 9] | 11 [6; 16] | 0.004 |
Propofol—n (%) | 83 (59.3) | 8 (36.4) | 75 (63.6) | 0.017 |
Propofol—median [IQR] | 2 [0; 6] | 0 [0; 3] | 2 [0; 7] | 0.027 |